Cargando…

Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19

Detalles Bibliográficos
Autores principales: Blaess, Markus, Kaiser, Lars, Sommerfeld, Oliver, Rentschler, Simone, Csuk, René, Deigner, Hans-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938238/
https://www.ncbi.nlm.nih.gov/pubmed/33692684
http://dx.doi.org/10.3389/fphar.2020.584881
_version_ 1783661559235477504
author Blaess, Markus
Kaiser, Lars
Sommerfeld, Oliver
Rentschler, Simone
Csuk, René
Deigner, Hans-Peter
author_facet Blaess, Markus
Kaiser, Lars
Sommerfeld, Oliver
Rentschler, Simone
Csuk, René
Deigner, Hans-Peter
author_sort Blaess, Markus
collection PubMed
description
format Online
Article
Text
id pubmed-7938238
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79382382021-03-09 Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19 Blaess, Markus Kaiser, Lars Sommerfeld, Oliver Rentschler, Simone Csuk, René Deigner, Hans-Peter Front Pharmacol Pharmacology Frontiers Media S.A. 2020-11-20 /pmc/articles/PMC7938238/ /pubmed/33692684 http://dx.doi.org/10.3389/fphar.2020.584881 Text en Copyright © 2020 Blaess, Kaiser, Sommerfeld, Rentschler, Csuk and Deigner. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Blaess, Markus
Kaiser, Lars
Sommerfeld, Oliver
Rentschler, Simone
Csuk, René
Deigner, Hans-Peter
Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19
title Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19
title_full Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19
title_fullStr Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19
title_full_unstemmed Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19
title_short Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19
title_sort rational drug repurposing: focus on lysosomotropism, targets in disease process, drug profile, and pulmonary tissue accumulation in sars-cov-2 infection/covid-19
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938238/
https://www.ncbi.nlm.nih.gov/pubmed/33692684
http://dx.doi.org/10.3389/fphar.2020.584881
work_keys_str_mv AT blaessmarkus rationaldrugrepurposingfocusonlysosomotropismtargetsindiseaseprocessdrugprofileandpulmonarytissueaccumulationinsarscov2infectioncovid19
AT kaiserlars rationaldrugrepurposingfocusonlysosomotropismtargetsindiseaseprocessdrugprofileandpulmonarytissueaccumulationinsarscov2infectioncovid19
AT sommerfeldoliver rationaldrugrepurposingfocusonlysosomotropismtargetsindiseaseprocessdrugprofileandpulmonarytissueaccumulationinsarscov2infectioncovid19
AT rentschlersimone rationaldrugrepurposingfocusonlysosomotropismtargetsindiseaseprocessdrugprofileandpulmonarytissueaccumulationinsarscov2infectioncovid19
AT csukrene rationaldrugrepurposingfocusonlysosomotropismtargetsindiseaseprocessdrugprofileandpulmonarytissueaccumulationinsarscov2infectioncovid19
AT deignerhanspeter rationaldrugrepurposingfocusonlysosomotropismtargetsindiseaseprocessdrugprofileandpulmonarytissueaccumulationinsarscov2infectioncovid19